DESIGN AND APPLICATION OF A PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL FOR TCDD DOSE-RESPONSE MODELING AS A TOOL FOR HUMAN RISK ASSESSMENT.

by | Aug 8, 2018